HomeTOP STORIESAtaiBeckley weighing options for lead psychedelic therapy: Bloomberg AtaiBeckley weighing options for lead psychedelic therapy: Bloomberg By rogerjudd March 7, 2026 FacebookTwitterPinterestWhatsApp Post Content Previous articleRoche continues to expect tariff impact on diagnostics despite U.S. dealNext articleSA Asks: What are the best defense stocks right now for investors? latest articles European indexes in red over oil market concerns Earnings Snapshot: Groupon Q4 North America local revenue +4%, billings +9% UK’s Hill & Smith to acquire Freeberg Industrial Fabrication Stellantis prices perpetual hybrid bonds offering China’s Cosco Shipping stops Panama port activities as tensions escalate AeroVironment updates FY26 guidance to $1.85B-$1.95B as SCAR contract ends and commercial transition accelerates explore more European indexes in red over oil market concerns Earnings Snapshot: Groupon Q4 North America local revenue +4%, billings +9% UK’s Hill & Smith to acquire Freeberg Industrial Fabrication Stellantis prices perpetual hybrid bonds offering China’s Cosco Shipping stops Panama port activities as tensions escalate AeroVironment updates FY26 guidance to $1.85B-$1.95B as SCAR contract ends and commercial transition accelerates
